Ubiquitin-conjugating Enzymes in Cancer.
Ubiquitin-conjugating enzymes (E2s) are emerging as critical regulators of oncogenic signaling networks by modulating protein stability, localization, and interactome dynamics.
APA
Yao Z, Peng T, et al. (2026). Ubiquitin-conjugating Enzymes in Cancer.. International journal of biological sciences, 22(6), 3244-3271. https://doi.org/10.7150/ijbs.130297
MLA
Yao Z, et al.. "Ubiquitin-conjugating Enzymes in Cancer.." International journal of biological sciences, vol. 22, no. 6, 2026, pp. 3244-3271.
PMID
41943832
Abstract
Ubiquitin-conjugating enzymes (E2s) are emerging as critical regulators of oncogenic signaling networks by modulating protein stability, localization, and interactome dynamics. Distinct E2s orchestrate ubiquitin chain topology to drive cancer hallmarks including proliferation, immune evasion, metastasis, and metabolic reprogramming. Despite their central role in the ubiquitin-proteasome system, E2s remain underexploited as therapeutic targets. This review systematically maps E2-mediated signaling mechanisms across cancer types and proposes translational strategies for E2-targeted intervention.
MeSH Terms
Humans; Neoplasms; Ubiquitin-Conjugating Enzymes; Animals; Signal Transduction; Ubiquitin
같은 제1저자의 인용 많은 논문 (5)
- The evolving role of neoadjuvant immunotherapy in resectable non-small cell lung cancer: a narrative review.
- Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adenocarcinoma of the body and tail: a systematic review and meta-analysis.
- Dual-targeting CD133/PD-L1 CAR-T plus αPD-1 overcomes immunosuppressive microenvironment and enhanced by radiation pre-conditioning.
- TCMNet: dynamic tanh enhanced 3D transformer with cascaded multiplicative fusion for pulmonary nodule detection.
- A label-aware diffusion model for weakly supervised deformable registration of multimodal MRI-TRUS in prostate cancer.